Description
An inhibitor of class I (IC50s = 0.1, 0.11, 0.02, 0.61 μM for HDAC1, -2, -3, and -8, respectively) and class IIb HDACs (IC50s = 7 and 40 nM for HDAC6 and HDAC10, respectively); selective for class I and class IIb over class IIa HDACs (IC50s = >50 μM for HDAC4, -5, -7, and -9); reduces proliferation of HOS, MG-63, RD, A204, SK-ES-1, and A673 sarcoma CSCs; increases levels of acetylated histone H3 and acetylated tubulin and induces apoptosis in MG-63 CSCs at 2 μM; reactivates HIV-1 in JLAT 10.6 latently-infected cells (EC50 = 350 nM)
Formal name: 5-[(4-[1,1′-biphenyl]-4-yl-1,6-dihydro-6-oxo-2-pyrimidinyl)thio]-N-hydroxy-pentanamide
Synonyms:
Molecular weight: 395.5
CAS: 1776116-74-5
Purity: ≥98%
Formulation: A solid